Comment on ‘Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study’

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Dankner, Matthew, Rose, April A. N.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Correspondence
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943260/
https://ncbi.nlm.nih.gov/pubmed/29563631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0012-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados